Literature DB >> 19222404

High cortisol awakening response is associated with an impairment of the effect of bright light therapy.

K Martiny1, M Lunde, M Undén, H Dam, P Bech.   

Abstract

OBJECTIVE: We investigated the predictive validity of the cortisol awakening response (CAR) in patients with non-seasonal major depression.
METHOD: Patients were treated with sertraline in combination with bright or dim light therapy for a 5-week period. Saliva cortisol levels were measured in 63 patients, as an awakening profile, before medication and light therapy started. The CAR was calculated by using three time-points: awakening and 20 and 60 min after awakening.
RESULTS: Patients with low CAR had a very substantial effect of bright light therapy compared with dim light therapy, whereas patients with a high CAR had no effect of bright light therapy compared with dim light therapy.
CONCLUSION: High CAR was associated with an impairment of the effect of bright light therapy. This result raises the question of whether bright light acts through a mechanism different from that of antidepressants.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19222404     DOI: 10.1111/j.1600-0447.2009.01359.x

Source DB:  PubMed          Journal:  Acta Psychiatr Scand        ISSN: 0001-690X            Impact factor:   6.392


  4 in total

1.  The association of post-stroke anhedonia with salivary cortisol levels and stroke lesion in hippocampal/parahippocampal region.

Authors:  Luisa Terroni; Edson Amaro; Dan V Iosifescu; Patricia Mattos; Fabio I Yamamoto; Gisela Tinone; Adriana B Conforto; Matildes Fm Sobreiro; Valeri D Guajardo; Mara Cristina S De Lucia; Ayrton C Moreira; Milberto Scaff; Claudia C Leite; Renerio Fraguas
Journal:  Neuropsychiatr Dis Treat       Date:  2015-02-03       Impact factor: 2.570

2.  Circadian reinforcement therapy in combination with electronic self-monitoring to facilitate a safe post-discharge period of patients with depression by stabilizing sleep: protocol of a randomized controlled trial.

Authors:  Signe Dunker Svendsen; Anne Sofie Aggestrup; Lasse Benn Nørregaard; Philip Løventoft; Anne Præstegaard; Konstantin V Danilenko; Mads Frost; Ulla Knorr; Ida Hageman; Lars Vedel Kessing; Klaus Martiny
Journal:  BMC Psychiatry       Date:  2019-04-25       Impact factor: 3.630

3.  Serum Cortisol, Nesfatin-1, and IL-1β: Potential Diagnostic Biomarkers in Elderly Patients with Treatment-Resistant Depression.

Authors:  Xiaoping Wu; Biao Dai; Fanfan Yan; Yang Chen; Yayun Xu; Qingrong Xia; Xulai Zhang
Journal:  Clin Interv Aging       Date:  2022-04-21       Impact factor: 3.829

4.  Adolescent depression: Study protocol for a randomized, controlled, double-blind multicenter parallel group trial of Bright Light Therapy in a naturalistic inpatient setting (DeLight).

Authors:  Martin Holtmann; Laura Mokros; Inken Kirschbaum-Lesch; Michael Kölch; Paul L Plener; Christian Ruckes; Michael Schulte-Markwort; Tanja Legenbauer
Journal:  Trials       Date:  2018-10-19       Impact factor: 2.279

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.